ArticleScientific reports2025
The association between Oxford Acute Severity of Illness Score and mortality in critical hemorrhagic stroke patients: a retrospective cohort study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Charlson index predicts thirtyday mortality in critically ill stroke patients MIMICIV retrospective study.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hemorrhagic stroke is a kind of disastrous cerebrovascular disease, Oxford Acute Severity of Illness Score (OASIS) was only evaluated among mixed critically ill patients, its predictive value in hemorrhagic stroke patients remains undiscovered. Evaluate the association between Oxford Acute Severity of Illness Score (OASIS) and mortality in critical hemorrhagic stroke patients. A retrospective cohort study. Data were extracted from a public database named Medical Information Mart for Intensive Care III (MIMIC-III). 1838 critical hemorrhagic stroke patients were included, multivariable logistic regression and receiver operating characteristic (ROC) curves were mainly used to analyze data. ROC curve analyses were also conducted in hemorrhagic stroke patients stratified by Glasgow Coma Scale (GCS) as subgroup analyses. The primary outcome was 30-day mortality. The sample size of this study is 1838 patients. The OASIS was significantly correlated with 30-day mortality (Odds ratio (OR) 1.125 per one-point increase, 95% confidence interval (CI) [1.107-1.144], p < 0.0001), the area under the ROC curve (AUC) of OASIS was comparable to that of Simplified Acute Physiology Score II (SAPSII) for predicting 30-day mortality (AUC: 0.7702 vs. 0.788, P = 0.096). Sensitivity analyses showed the results were stable. In subgroup analyses OASIS also has the similar discriminatory power to predict 30-day mortality for the severe (GCS 3-8) and mild (13-15) hemorrhagic stroke patients, but it has lower discriminatory power to predict 30-day mortality for the moderate (9-12) patients. The OASIS might serve as an alternative choice to predict outcomes of severe and mild hemorrhagic stroke patients in consideration of the practicality. Selection bias was unavoidable because this study was a retrospective observational study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.